Post Transplant Study

Amgen50 enrolled

Overview

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

Study Type

OBSERVATIONAL

Enrollment

Conditions

Kidney Tansplant Secondary Hyperparathyroidism Hyperparathyroidism

Interventions

Sensipar after Post TransplantDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults \>= 18 years old * Subjects who have received Sensipar for a duration of at least 3 months, beginning at least 3 months after a kidney transplant. Subjects must have begun Sensipar teatment no later than Februry 28, 2005 at treating physician's discretion. Exclusion Criteria: * Subjects who received Sensipar before undergoing a kidney transplant * Subjects receiving dialysis post-transplant

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.